Personalis, Inc. announced today that data presented at the American Society for Clinical Oncology (ASCO) oral podium talks in Chicago, IL demonstrated that the Personalis NeXT Personal test had exceptional detection rates and performance for...
A new type of blood test can predict the recurrence of breast cancer in high-risk patients, months or even years before they relapse, research has shown.
'Ultra-sensitive' cancer blood test is highly accurate in identifying which breast cancer patients will relapse The 'Personalis NeXT Personal® liquid biopsy' test uses whole genome sequencing
The cheap test - which looks for genetic markers of the cancer in people's DNA - was more effective than the current blood test men can request from their GP.